















httpEndovascular treatment for isolated acute
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Background: Isolated acute abdominal aortic dissection (IAAAD) is considered an unusual clinical entity and is tradi-
tionally treated by open surgical repair. We report our single-center experience during the last 9 years, evaluating the
outcomes after endovascular repair in this patient population.
Methods: All patients with a diagnosis of IAAAD treated in our institute were included in this retrospective review.
Between January 2004 and December 2012, 38 patients suffering from an acute aortic dissection were referred regionally
for intervention to our department: 24 (63.2%) with a thoracic aortic dissection type B and 14 patients (36.8%, all male;
median age, 65 years) with an IAAAD. Demographics, perioperative, procedure-speciﬁc, and follow-up data were
prospectively aggregated in an electronic database.
Results: Patients suffering from IAAAD presented with acute abdominal pain (n [ 13) and acute lumbar pain (n [ 1).
Insufferable pain and enlargement of the aorta were the main indications for treatment. Mean (6 standard deviation)
maximal abdominal aortic diameter at presentation was 3.5 6 0.94 cm (range, 2.6-5.1 cm). None of these patients had
a concomitant thoracic aortic dissection. All patients were treated by endovascular means, with a primary technical success
rate of 100%. Two patients (14%) died perioperatively from cardiac causes. Median hospital stay was 4.5 days (range,
3-16 days). During a mean follow-up period of 37.41 6 23.56 months (range, 8-82 months; median, 32.5 months), two
patients experienced primary treatment failure needing reintervention that led to a successful outcome. The cumulative
free-from-reintervention rate was estimated 90.9% at 58 months (standard error, 8.7%). A full aortic remodeling without
any events was noted in all other patients during the follow-up period.
Conclusions: Based on our series, IAAADmay represent a not so rare clinical entity as generally thought, suggesting that it
may be underdiagnosed. Endovascular treatment of IAAAD appears to be a feasible and efﬁcient therapeutic approach
and might be considered as the ﬁrst-line treatment in all patients with suitable anatomy. (J Vasc Surg 2013;58:1505-11.)Acute aortic dissection most commonly involves the
thoracic aorta and may extend in an antegrade fashion to
the abdominal aorta.1 Unlike dissection of the thoracic
aorta, isolated acute dissection of the abdominal aorta
(IAAAD) has been considered an unusual event presenting
with various clinical signs.2,3 The natural course of the
disease as well as the therapeutic options are not well char-
acterized since data are limited to individual case reports
and small patient series. Open repair of IAAAD has been
considered the mainstay of treatment with acceptable
results.1-3 The advent and applicability of endovascular
stent grafts for aneurysms involving the abdominal aorta
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://dx.doi.org/10.1016/j.jvs.2013.05.025Endovascular therapy appears to be associated with rela-
tively low mortality, fewer complications, and earlier
discharge when compared with open repair. However, in
the clinical setting of IAAAD, data remain inconclusive.4
The aim of this retrospective study was to report our
single-center experience during the last 9 years in this
patient population and to evaluate the outcomes after
endovascular treatment.
METHODS
Between January 2004 and December 2012, 38
patients suffering from an acute aortic dissection were
referred for intervention to our department: 24 (63.2%)
with a thoracic aortic dissection type B and 14 patients
(36.8%) with an IAAAD. IAAAD was deﬁned as any acute
aortic dissection involving the aorta below the diaphragm
and presenting <14 days of symptom onset.2,5 Only
patients suffering from IAAAD were included in the
present analysis. Patients with concomitant thoracic aortic
dissection were excluded from this report. All patients
underwent preoperative computed tomography angiog-
raphy (CTA) to determine the extent of the dissection,
possible location of proximal tear, and diameter of blood
vessels. In those cases where digital DICOM data were
available, the Osirix workstation (Pixmeo, Bernex,
Switzerland) was used for three-dimensional imaging
measurements after September 2008.1505
Table I. Demographics and history of patients
undergoing endovascular repair of isolated acute
abdominal aortic dissection (IAAAD)
Variables No. (%)
Age, years 64.8 6 10.61a




Coronary heart disease 10 (71.4)
Diabetes mellitus 2 (14.3)
Cardiac insufﬁciency 2 (14.3)
Chronic obstructive pulmonary disease 7 (50)
Active smoker 6 (42.8)
Ex-smoker 3 (21.4)
Abdominal aorta maximum diameter, cm 3.5 6 0.94a
Dissection length, mm 53.8 6 31.8a
Distance from the lowest renal, mm 43.7 6 26a
Contrast media, mL 117 6 4.94a
Duration of procedure, minutes 118 6 27.13a
Time to discharge, median/days 4.5
aMean 6 standard deviation.
bFrom references 2,4.
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aortic rupture, limb ischemia, unremitting pain, and aortic
diameter exceeding 3 cm. Unremitting pain was deﬁned as
pain not amenable to analgesic therapy, even with opioids,
for at least 48 hours. It was the policy in our institution to
offer endovascular treatment as the ﬁrst-line therapy in all
patients with IAAAD. Informed consent for this procedure
was obtained from all patients. All endovascular procedures
were recorded on a prospectively maintained database with
regard to demographics, operative time, blood loss, contrast
media use, renal function, patient outcome, length of stay,
and complications. All procedures were performed in a fully
equipped operating room with the patient under general or
regional anesthesia. All patients were treated by the same
surgical and anesthesiology team. Every effort was made
to follow the selection criteria recommended by the manu-
facturer of the device. However, the decision as to which
device to use was based on surgeon’s critical preference,
according to the anatomic characteristics of the proximal
neck, the iliac conﬁguration, and the presence of thrombus
or calciﬁcation. Every effort was made to deploy the endo-
vascular device just below the level of the lowest renal artery.
The grafts deployed were Excluder (W. L. Gore & Associ-
ates, Flagstaff, Ariz), Talent, and Endurant (Medtronic
Corp, Minneapolis, Minn).
All patients underwent a postoperative surveillance
protocol, which included physical examination, blood pres-
sure measurement, and CTA at 1, 6, and 12 months post-
operatively and yearly thereafter. CT scans were eliminated
after full remodeling of the aorta was achieved and ultra-
sound scans performed thereafter.
Statistical analysis. Data are expressed as mean 6
standard deviation, except for non-Gaussian parameters,
which are presented as median (range). Categorical data
are represented by number (n) and percentage (%). Kaplan-
Maier analysis was used to estimate survival rates. Statistical
analyses were performed using SPSS 20.0 statistics software
(SPSS Inc, Chicago, Ill). A P value of <.05 was considered
as statistically signiﬁcant.
RESULTS
Patients’ demographics and preoperative and postoper-
ative data are shown in Table I, and a summary of all cases
reported herein is delineated in Table II. The group con-
sisted of 14 male patients with a mean age at diagnosis of
64.8 6 10.6 years (range, 48 to 85 years). History of
hypertension was present in all patients. The majority of
patients had coronary artery disease (71.4%) and hyperlip-
idemia (85.7%), while nearly half were active smokers.
IAAAD was considered to be spontaneous in all cases,
as there was no evidence of iatrogenic or traumatic causes
in any of these patients. None of the patients had Marfan
syndrome, history of a prior aortic dissection, or had under-
gone an aortic procedure for dissection or aneurysm. All
patients experienced sudden onset of severe pain. The
pain was described as abdominal in 13 patients (92.9%)
and as lumbar in one patient (7.1%). The diagnosis of
abdominal aortic dissection was made with CTA ofthe thoracic and abdominal aorta in all patients (Figs 1
and 2). In all cases, CTA of the thoracic aorta revealed
no evidence of aortic dissection. The mean maximal
abdominal aortic diameter at presentation was 3.5 6
0.94 cm (range, 2.6-5.1 cm). In two patients (14%) under-
going surveillance of known small abdominal aortic aneu-
rysms (3.5 cm and 3.9 cm, respectively), their abdominal
aorta increased in diameter with the onset of pain (from
3.5-4 cm and 3.9-5.1 cm, respectively). The dissection
originated from the infrarenal part of the aorta in all
patients, at a mean distance from the lowest renal artery
of 43.7 6 26 mm (range, 10-90 mm). In three patients,
the dissection extended distally from the aortic bifurcation
to the iliac arteries. The length of the dissection ranged
from 10 mm to 88 mm (mean length, 53.8 6 31.8 mm)
as measured in abdominal CT.
Therapeutic intervention by endovascular means was
performed in all patients. General anesthesia was used in
12 patients, while two patients received regional anesthesia.
Ten patients were treated with a bifurcated stent graft.
In half of them, a graft with suprarenal ﬁxation was
deployed (Fig 3). Two patients were treated with deploy-
ment of an aortic tube graft. One of these patients had
a limited focal dissection, while in the other, an aortic bifur-
cation <20 mm in diameter excluded the deployment of
a bifurcated stent graft. In two patients, aorto-uni-iliac
stent grafts were used followed by femoral-femoral bypass
due to signiﬁcant atherosclerotic stenosis of the distal aorta
in one. In the other, a very short abdominal aorta did not
allow the deployment of a bifurcated graft. Primary tech-
nical success was 100%, and no reoperation was required
in the postoperative period.
The overall 30-day mortality was 14% (n ¼ 2). One
patient died on postoperative day 4 of an extensive acute
myocardial infarction. The other patient, who died from
JOURNAL OF VASCULAR SURGERY
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previous severe chronic cardiac and renal insufﬁciency.
No variables were signiﬁcantly associated with in-hospital
mortality. Median hospital stay for the patients who sur-
vived was 4.5 days (range, 3-16 days).
During a mean follow-up period of 37.41 6
23.56 months (range, 8-82 months; median, 32.5 months),
two patients needed reintervention. One patient presented
2 years after the primary operation with an extension of
the dissection to the right iliac artery both proximally
and distally to the stent graft limb. He was treated
successfully by stenting of the common and external iliac
artery (Fig 4). The other patient presented with a type I
endoleak 6 months after the deployment of an aorto-uni-
iliac device for an infrarenal abdominal aortic dissection
just 8 mm below the renal arteries. The endoleak was
successfully treated with open surgery by external banding
of the infrarenal aorta. The cumulative free-from-
reintervention rate was estimated at 90.9% at 58 months
(standard error, 8.7%). One patient died 12 months after
the procedure of a cancer-related illness. Recurrence of
new symptoms or abdominal pain was not observed in
any patient.
DISCUSSION
IAAAD has been generally considered a rare event
accounting for only 1% to 4% of all aortic dissections.2,6
Trimarchi et al evaluated 1417 patients of the International
Registry of Acute Aortic Dissection and found IAAAD in
just 1.3%. On the contrary, VanMaele et al reported
a single-center experience of ﬁve cases within a 2-year
period.2,7 A review of the literature by Jonker et al in
2009 yielded 73 patients reporting with this disorder.4
According to our data, IAAAD is not a so infrequent clin-
ical entity as it was generally thought. The number of
patients treated for IAAAD during the last 9 years at our
institution reﬂects referrals from the whole geographic
area of North-Western Greece and accounted for half of
thoracic aortic type B dissections that needed intervention
during the same time period. The liberal use of diagnostic
CT scan imaging for evaluation of abdominal pain may play
a role in identifying this event with increased frequency.
The patient cohort’s mean age at presentation was in
the 6th decade of life, similar to that reported by relevant
studies.1,8 Predisposing factors of IAAAD appear to be
similar to those of thoracic dissection. Abdominal aortic
dissection has been associated with atherosclerosis in nearly
half of the patients and hypertension in up to 80%.4 In the
present cohort, all patients suffered from hypertension and
presented with at least one additional predisposing athero-
sclerotic factor. These patients are often frail with signiﬁ-
cant comorbidities and are considered a high-risk group
that would beneﬁt from treatment with less-invasive thera-
peutic methods.
Abdominal pain was present in the vast majority of our
patients and was also the most common presenting
symptom in 49% to 68.7% of patients reported in several
other series.2,8,9 In the present report, none of the patientshad acute lower limb ischemia, in contrast to the 25%
reported by Trimarchi et al2 Additionally in the present
series, the dissection extended to the iliac artery just in
three patients.
Our current knowledge regarding the optimal thera-
peutic approach in aortic dissections comes mostly from
studies involving the thoracic aorta.10,11 Few recommenda-
tions regarding the therapeutic strategy for IAAAD have
been postulated thus far. Asymptomatic patients with a
nondilated aorta could be treated conservatively by means
of antihypertensive medication and careful follow-up.
Despite the lack of clear evidence and based on knowledge
coming from thoracic dissections, it seems reasonable that
patients with IAAAD in whom abdominal pain resolves
and no other complications occur should also be followed
conservatively. Clinical ﬁndings and the development of
complications are important parameters when considering
treatment options. Patients with signs of rupture, visceral
vessel involvement, or acute limb ischemia require surgical
intervention. Aortic rupture in abdominal aortic dissection
occurred in nearly 10% of patients reported by Jonker et al
and was associated with higher mortality.4 The presence of
unremitting acute abdominal pain, as observed in half of
our patients, or suprarenal aortic involvement could also
be considered indications for intervention, since they have
been associated with a worse outcome if left untreated.9
Unrelenting pain despite the control of blood pressure
should be meticulously evaluated once other possible etiol-
ogies have been excluded. Speciﬁc characteristics or the
duration of pain may necessitate the need for prompt
surgical repair and must be carefully considered for each
individual patient in the absence of deﬁnitive treatment
guidelines.3 In our practice, we put the patient under anal-
gesic therapy, even with opioids when needed. If, after the
completion of the ﬁrst 48 hours, the pain does not remit,
we consider it a high risk of rupture or complications and
an indication for invasive treatment.
The natural history of IAAAD is unknown. Deter-
mining the exact proportion of patients suffering with
IAAAD is impossible, since there could have been a signif-
icant number of patients with undiagnosed IAAAD that
have not been referred to an adequate center. Aortic dissec-
tion may cause aneurysmal degeneration of the aorta. The
patients in our study presented with a mean maximal aortic
diameter approaching 3.5 cm. Two patients (14.2%) had
known abdominal aortic aneurysms, a rate lower than the
30% to 44% reported in the literature.2,3,12 Most reported
studies do not address whether the aortic dilatation pre-
existed or was a result of the dissection itself. The coexis-
tence of IAAAD and a signiﬁcant aortic dilatation has
been proposed as an absolute indication for repair based
on the signiﬁcant risk of rupture.3,9 Dissection weakens
the integrity of the abdominal wall, allowing for an increase
in wall tension of the dilated aorta due to both decreased
vessel wall thickness and increased luminal radius.3 To
date, the aortic diameter cutoff point that may necessitate
intervention is poorly deﬁned. In thoracic aortic dissection
type B, an aortic diameter around 5 cm has been
Table II. Summary of all cases undergoing endovascular repair of isolated acute abdominal aortic dissection (IAAAD)
Pt Age, years/gendera AA diameter Symptom Indication Distance from the lowest RA, mm
1 73 45 Abdominal pain AD exceeding 3 cm 20
2 50 39 Abdominal pain AD exceeding 3 cm 23
3 66 37 Abdominal pain AD exceeding 3 cm 25
4 48 26 Abdominal pain Unremitting pain 90
5 80 30 Abdominal pain Unremitting pain 25
6 68 27 Abdominal pain Unremitting pain 10
7 54 42 Abdominal pain AD exceeding 3 cm 70.5
8 63 51 Abdominal pain AD exceeding 3 cm 63
9 69 30 Lumbar pain Unremitting pain 40
10 58 30 Abdominal pain Unremitting pain 57
11 64 51 Abdominal pain AD exceeding 3 cm 50
12 85 26 Abdominal pain Unremitting pain 10
13 70 40 Abdominal pain AD exceeding 3 cm 80
14 59 28 Abdominal pain Unremitting pain 48
AA, Abdominal aorta; AD, aortic diameter; Lt, left; N, No; Pt, patient; RA, renal artery; Rt, right; Y, yes.
aAll male.
Fig 1. Computed tomography angiography (CTA; axial images) revealing the dissection of the abdominal aorta in two
different patients with normal aortic diameter (A) and with dilatation of the affected aorta (B).
Fig 2. Computed tomography angiography (CTA; axial images) showing a dissection originating from the abdominal
aorta (A) and extending to the right iliac artery (B).
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intervention.13 During surveillance of these patients, two
groups reported that an even smaller maximum diameter
(>4 cm) was predictive of an aortic event and recommen-
ded an even more aggressive therapeutic approach.14,15
Based on this knowledge and considering the smaller
caliber of the abdominal aorta, Mantelas et al and Farberet al recommend lowering the threshold of aortic diameter
in comparison to that of the thoracic aorta and consider all
patients with IAAAD whose aortic diameters exceed 3 cm
as candidates for surgical repair.1,3 Our policy is in agree-
ment with this approach, and we considered an infrarenal
aortic enlargement above 3 cm an indication for
intervention.
Length, mm Iliac extension Anesthesia Stent graft Hospital stay, days Outcome Follow-up, months Reinterventions
72 N Regional Talent 4 Death – –
66 N General Excluder 16 Survival 82 None
33.5 N General Excluder 7 Survival 58 None
84 Y (Rt) Regional Excluder 4 Survival 75 Rt iliac dissection (2 years)
61 N General Talent 11 Death – –
10 N General Endoﬁt 3 Survival 40 None
12 N General Excluder 3 Survival 42 None
28.5 N General Endurant 5 Survival 33 None
30 N General Endurant 10 Survival 32 None
9 N General Excluder 6 Survival 25 None
90 Y (Rt) General Endurant 6 Survival 24 None
85 N Regional Endurant 5 Survival 16 None
90 Y (Lt) General Endurant 8 Survival 14 Endoleak I-aortic banding
82 N General Endurant 3 Survival 8 None
Table II. Continued.
Fig 3. A and B, Axial images and three-dimensional reconstruction of computed tomography angiography (CTA)
showing a dissection of the infrarenal aorta. C, Postoperative result 12 months after the deployment of a stent graft with
suprarenal ﬁxation.
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surgical treatment. Jonker et al, in their meta-analysis of
published clinical reports assessing treatment of chronic
or acute abdominal aortic dissection, found that open
surgery was performed in 50% of the patients, endovascular
therapy in nearly 20%, and the remaining 30% managed
conservatively.4 The reported 4.3% mortality rate referred
to four patients who all suffered from acute dissection.
Interestingly, only one of these four patients was operated
on, “speculating” that a more aggressive approach might
perhaps be justiﬁed. Historically, conventional open
surgical repair has been the mainstay of treatment in such
cases, with good long-term results especially in patients
with acceptable operative risk.1-3
Endovascular therapy is considered a less-invasive
approach. Despite the limited number of patients treated
so far, it has been associated with low mortality and few
complications. This technique avoids aortic cross-clamping
and suturing in a highly friable aortic wall. As shown in our
study, if the length of the dissection is limited to the
abdominal aorta and does not extend to the iliacarteries, coverage of the whole dissection is possible with
a single graft. Covering the primary entry point and
applying the radial force of the graft across the whole
length of the dissection, a better false lumen thrombosis
can be achieved. Nonetheless, certain anatomical parame-
ters, such as the distance from the lowest renal artery
as well as the successful deployment of the contralateral
limb in a nonaneurysmal dissected aorta, should meticu-
lously be evaluated and measured in the preoperative
CTA. If the distance between the lowest renal artery
and the dissection’s origin is adequate and the conﬁgura-
tion of the aorta is anatomically suitable, a stent graft
with infrarenal ﬁxation might be preferred. However,
many times, mostly due to anatomic restrictions or graft
availability in the acute setting, a graft with suprarenal ﬁxa-
tion is deployed despite the presence of an adequate
distance. We must also keep in mind that endovascular
treatment of IAAAD is totally different from endovascular
aneurysm repair, and securing the proximal part of a fragile
dissected aorta with a suprarenal active ﬁxation graft may
lead to a better outcome. In case of an aortic bifurcation
Fig 4. Three-dimensional reconstruction of computed tomography angiography (CTA) of one patient that needed
reintervention showing the extension of the dissection to the right iliac artery (white arrow) (A) and the postoperative
result 1 month after stenting of the common and external iliac arteries, preserving blood ﬂow to the internal iliac
artery (B).
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a tube stent graft to cover the proximal tear should be
considered. An aorto-uni-iliac device would also have
been a treatment option, although the need for an extra-
anatomic bypass and its possible complications should be
acknowledged.
In this cohort, two patients died at the immediate
postoperative period, yielding a periprocedural mortality
rate of nearly 14%. This rate seems quite signiﬁcant consid-
ering no patients had rupture. Jonker et al, in their meta-
analysis, reported an in-hospital mortality rate of 4% in
92 patients treated for abdominal dissection, although
75% of them had acute presentations.4 The two patients
who died in our series had signiﬁcant comorbidities, and
their death was not related to the dissection. It seems
that, despite the minimally invasive nature of the endovas-
cular procedure, the preoperative state of the patient plays
a signiﬁcant role according to outcome. To our knowledge,
the present report consists of the largest series of endovas-
cular repair of IAAAD reported to date. The outcome of
our patients shows that endovascular management of
IAAAD is an effective therapeutic approach with acceptable
and durable results. Given the good results of endovascular
repair of the thoracic aorta, we believe that it could become
the ﬁrst therapeutic option for treating IAAAD in cases
where the anatomical criteria are met.CONCLUSIONS
Based on our series, IAAAD represents a not-so-rare
clinical entity. Advanced imaging technology and improved
diagnostic procedures may account for this observation.
Our results demonstrate that endovascular therapy of
IAAAD is efﬁcacious with acceptable complications. This
therapeutic approach could become the treatment of
choice in all cases that are anatomically suitable. Future
efforts to establish a multicenter registry to evaluate the
prevalence of the disease and treatment options couldprovide better and more comprehensive guidelines for
the treatment of IAAAD.
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